Compare LYV & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYV | DXCM |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.7B | 34.4B |
| IPO Year | 2005 | 2005 |
| Metric | LYV | DXCM |
|---|---|---|
| Price | $172.88 | $78.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 29 |
| Target Price | ★ $202.63 | $96.46 |
| AVG Volume (30 Days) | 1.4M | ★ 3.5M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | N/A | ★ 1.15 |
| Revenue | ★ $25,201,406,000.00 | N/A |
| Revenue This Year | $11.59 | $12.14 |
| Revenue Next Year | $9.27 | $10.81 |
| P/E Ratio | ★ N/A | $67.96 |
| Revenue Growth | ★ 8.83 | N/A |
| 52 Week Low | $125.34 | $54.11 |
| 52 Week High | $189.25 | $92.59 |
| Indicator | LYV | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 32.21 |
| Support Level | $171.00 | $62.02 |
| Resistance Level | $174.45 | $79.03 |
| Average True Range (ATR) | 3.58 | 2.46 |
| MACD | 0.56 | -0.84 |
| Stochastic Oscillator | 56.01 | 12.31 |
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 51 countries, Live Nation promotes concerts globally. It owned, operated, or had exclusive booking rights to more than 400 venues worldwide at the end of 2025, which the firm says makes it the second-largest operator of music venues globally. In 2025, Live Nation promoted nearly 55,000 events, drawing roughly 160 million fans. Ticketmaster is a dominant global ticketing service, selling nearly 650 million tickets in 2025.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.